- About Breast Cancer
- Community Impact
- Get Involved
Finding Solutions Through Science, Scholars and Survivors Luncheon
Finding Solutions Through Science, Scholars & Survivors is a luncheon highlighting the impact of Susan G. Komen’s ® National Research Program upon local and national breast cancer research. This unique event brings together an audience of researchers, scientific thinkers, corporate and private philanthropists, survivors, co-survivors, and individuals impacted by the disease to learn more about how their donations are being used in local and national laboratories to find the cures.
Thank you to our Finding Solutions Through Science, Scholars & Survivors Sponsors
If you are unable to attend our Research Luncheon, please consider donating a ticket to allow a local survivor or researcher to attend the luncheon for free.
Dr. Daniel F. Hayes is the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center, where he is the Stuart B. Padnos Professor of Breast Cancer Research.
Dr. Hayes work has focused on development and validation of cancer biomarker tests such as HER-2, CA 15-3, Circulating rumor cells and pharmacogenomic markers. He has been instrumental in establishing international guidelines for the use of tumor biomarker tests, including criteria for their clinical utility.
Dr. Hayes is currently the chair of the SWOG Breast Cancer Translational Medicine Community. In 2015 he was elected to serve a three-year term as president of the American Society of Clinical Oncology. As a Fellow of ASCO, Dr Hayes serves on the Susan G. Komen for the Cure Scientific Advisory Council as a Komen Scholar.
Dr. Kimberly Blackwell
Dr. Kimberly Blackwell is a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University Medical Center.
Dr. Blackwell’s clinical and research interests include various topics in breast cancer including antibody drug conjugates, novel HER2 therapies, breast cancer vaccines and other experimental therapeutics.
Dr. Blackwell serves as the Co-Director of the Duke Cancer Institute’s Women’s Cancer Program, Assocatie Director for Strategic Relations at Duke Cancer Institute Global Research Scholar for Susan G. Komen and the Senior Strategist for the Duke Innovation and Entrepreneurship Program. Because of her work, TIME Magazine named her one of their 100 most influential people in the world in 2013.
Dr. Charles Perou is a Professor of Genetics, and of Pathology & Laboratory Medicine at the University of North Carolina.
Dr. Perou focuses on genomics, genetics and systems biology of breast cancer. His work in gene expression profiling has helped identify intrinsic subtypes of breast cancer that are a major factor in determining a prognosis. His research focus on using genomic information to determine the best possible course of action.
He currently serves as the Co-Director of the UNC Breast Cancer Program and the Faculty Director of the Lineberger Comprehensive Cancer Center Bioinformatics Group. In 2016, Dr. Perou received the Jill Rose Award for Distinguished Research and the Brinker Award for Scientific Distinction from the Susan G. Komen Foundation.
Dr. Erica Crosby is a postdoctoral fellow working with Dr Zachary Hartman and Dr. Kim Lyverly at Duke University.
Dr. Crosby has studied activation pathways that regulate immune responses and pathology observed during chronic infection. In the past two years, she has focused on applying this knowledge of immune activation to the development of novel immunotherapies for the treatment of breast cancer.
As a 2017 Komen Postoctoral Fellowship Award recipient, she focuses in understanding how to effectively combine standard of care therapies with cutting-edge immune targeting treatments to maximize their impact.